Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 127716

Known as: NSC-127716 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced… Expand
  • table 1
  • figure 2
  • table 2
  • table 3
  • figure 3
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
  • Corpus ID: 12205361
Decitabine [NSC 127716, DAC, dezocitidine, Aza dC, 2'-deoxy-5-azacytidine] is a deoxycytidine and cytarabine derivative with… Expand
Is this relevant?
Review
2003
Review
2003
Normal cell development and function is dependent upon controlled gene expression. DNA methylation is an epigenetic modification… Expand
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
  • Corpus ID: 43763463
Decitabine [NSC 127716, DAC, dezocitidine, Aza dC, 2'-deoxy-5-azacytidine, Dacogen( trade mark )] is a deoxycytidine and… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
The Early Clinical Trials Cooperative Group of the EORTC conducted several phase II studies with a pyrimidine analogue of… Expand
Is this relevant?
1986
1986
A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced… Expand
Is this relevant?